✦ LIBER ✦

The prevalence of patients with colorectal carcinoma under care in the U.S.

✍ Scribed by Angela Mariotto; Joan L. Warren; Kevin B. Knopf; Eric J. Feuer

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 153 KB
Volume: 98
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.11631

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

BACKGROUND

Prevalence usually is defined as the proportion of individuals alive who previously had a diagnosis of the disease, regardless of whether the individuals still are receiving treatment or are cured. The objective of this study was to estimate the proportion of elderly patients with colorectal carcinoma (CRC) in the U.S. that actually were receiving care for their disease as a better quantification of the burden of CRC.

METHODS

The authors used data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program linked to Medicare claims. Four phases of CRC care were defined: initial diagnosis and treatment, postdiagnostic monitoring, treatment for recurrent/metastatic disease, and terminal care. CRC care prevalence measures by phase were extrapolated to the U.S. population age 65 years and older.

RESULTS

For all patients with CRC who were diagnosed between 1975 and 1996, 62% received at least 1 service related to their CRC in 1996, and patients received an average of 2.1 months per person of CRC care. Among the U.S. population age 65 years and older, 1.81% had 1 diagnosis of CRC, and (1.81% × 0.62%) = 1.12% received at least 1 service related to their CRC. This translated to 380,783 individuals who received care and 1,210,121 person months of care during 1996.

CONCLUSIONS

To the authors' knowledge, this is the first report in which care prevalence has been estimated directly. The classification of CRC care by phases of care provides a very detailed picture of the amount of care delivered in the U.S. population. Person‐month estimates can be used to estimate the cost of CRC. Cancer 2003;98:1253–61. Published 2003 by the American Cancer Society.

DOI 10.1002/cncr.11631

📜 SIMILAR VOLUMES

The prevalence of psychiatric illness am

The prevalence of psychiatric illness among continuing-care patients under the care of departments of geriatric medicine

✍ John Bond; Ann Atkinson; Barbara A. Gregson 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

Between 1983 and 1987,568 patients in three centres, who were under the care of consultant physicians with a special interest in elderly people, were referred to a randomized controlled trial as part of the evaluation of the three experimental NHS nursing homes. All patients referred to the trial we

Racial differences in the outcome of pat

Racial differences in the outcome of patients with colorectal carcinoma

✍ Rangaswamy Govindarajan; Rajesh V. Shah; Linda G. Erkman; Laura F. Hutchins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Abstract ## BACKGROUND African‐American (AA) patients with colorectal carcinoma have a worse prognosis compared with Caucasians. To analyze the causes of this disparity in survival, a retrospective study of patients with colorectal carcinoma was undertaken. The impact of treatments received and

The significance of microsatellite insta

The significance of microsatellite instability in predicting the development of metachronous multiple colorectal carcinomas in patients with nonfamilial colorectal carcinoma

✍ Shigehiko Masubuchi; Fumio Konishi; Kazutomo Togashi; Tomomi Okamoto; Shingo Sen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 3 views

## BACKGROUND. Patients with metachronous multiple colorectal carcinomas have been reported to have a higher frequency of a family history of colorectal carcinoma, associated colorectal adenomas, and extracolonic malignancies. These clinicopathologic factors also are considered to be related to th

The prognostic significance of intratumo

The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma

✍ Santiago Coca; Javier Perez-Piqueras; David Martinez; Antonio Colmenarejo; Migue 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

## Background: Natural killer (nk) cells have a spontaneous cytotoxic capacity-against tumor cells. these cells represent a small proportion of human colon carcinoma-infiltrating lymphocytes. their prognostic significance in these tumors has yet to be determined. ## Methods: One hundred and fifty

The clinical significance of u-FCC, an a

The clinical significance of u-FCC, an antigen of anti-fucosylceramide antibody found in urine, in patients with gastric and colorectal carcinoma

✍ Takemaru Tanimizu; Hideki Ishihara; Hiroshi Hattori; Setsuo Hamada; Renzo Hiraya 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

## BACKGROUND. It has already been shown that the production of fucosylceramide, an aberrant glycolipid, is associated with neoplastic changes in human tissues. The authors of this study designed a sandwich radioimmunoassay (RIA) using a mouse monoclonal anti-fucosylceramide antibody, PC47H, design

A prospective pancreatographic study of

A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus

✍ Yoshiaki Ogawa; Masao Tanaka; Ken Inoue; Koji Yamaguchi; Kazuo Chijiiwa; Kazuhir 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract ## BACKGROUND The correlation between diabetes mellitus and pancreatic carcinoma is well documented, but no criteria have been established for the efficient selection of a high‐risk group among patients with diabetes mellitus. ## METHODS Eighty‐seven patients were selected prospectiv